BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Wall St hits bulls-eye with Colgate-Palmolive Q2 estimates

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections. Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion. Earnings, on an […]

July 26, 2019 2 min read

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion.

Earnings, on an adjusted basis, fell 6% to 72 cents per share, in line with the street estimates.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs,

Colgate stock gained 1% following the announcement of the results. CL shares have gained 22% so far this year.

READ: Alphabet reverses ad revenue deceleration trend in Q2, stock rises

ADVERTISEMENT

In North America, despite revenues increasing 2.5% year-over-year,
operating profits were down 4%. This was primarily due to higher raw and
packaging material costs, partially offset by cost savings from the company’s
funding-the-growth initiatives.

CEO Noel Wallace said, “Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.4% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.7% year to date.”

Outlook

The
company continues to expect 2019 net sales to be flat to up low-single-digits,
with organic sales up between 2% and 4%.

Excluding certain one-time costs, Colgate continue to plan for a year of
gross margin expansion, increased advertising investment and a mid-single-digit
decline in earnings per share.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT